Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

Δ4-THCΔ4-tetrahydrocannabinol (Δ6a,7-THC)

Synthetic THC isomer in Schedule I of the 1971 Convention, with no published pharmacology.

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₂₁H₃₀O₂

CAS 59042-44-3

Family
Synthetic CB receptor agonistResearch ligand or medicine
Molar mass
314.46 g/mol

Updated on

In plain terms

Δ4-THC is a laboratory-made variant of THC whose double bond sits elsewhere. It is classed as a controlled drug by the 1971 international convention, although its effects have not been studied.

Receptors and activity

    Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

    Pharmacology

    Δ4-THC, or Δ6a,7-THC in dibenzopyran numbering, is a positional isomer of tetrahydrocannabinol whose double bond lies between carbons 6a and 7. Arnone, Merlini and Servi described its synthesis in 1975, and, according to the 2018 WHO critical review, only the 9R,10aR isomer has been described, as a viscous oil. Schedule I of the 1971 Convention on Psychotropic Substances lists six isomers of Δ9-THC, this one among them, with their stereochemical variants; the WHO noted in 2018 that these isomers had never been subject to a critical review. The same report places Δ6a,7-THC among the isomers not assessed in any detail for toxicity and states that it may never have been tested for pharmacological activity; only Δ8-THC and Δ6a,10a-THC have been given to humans in pure form. No cannabinoid receptor affinity is published.

    History

    Source
    A positional isomer of tetrahydrocannabinol obtained by total synthesis, not isolated from the plant and with no source describing its formation from a plant extract. Its double bond lies between carbons 6a and 7 (dibenzopyran numbering), at the junction of the central ring and the terpenoid ring, hence its other name Δ6a,7-THC; terpenoid numbering calls it Δ4-THC.

    Origin

    Laboratory synthesis

    No plant pathway. The only described preparation (Arnone et al. 1975) belongs to the acid condensation of an olivetol-type phenol with a monoterpenoid precursor, the class of reactions that forms the dibenzopyran skeleton.

    Classification

    Family, origin and source verification

    Family

    Synthetic CB receptor agonist › Research ligand or medicine

    Chemistry

    C5 side chain · neutral form

    Class

    classical

    Verification

    Every fact on this entry was checked against its primary sources on 20 October 2026.

    Wikipedia (English)

    Δ4-Tetrahydrocannabinol (new tab)

    Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

    References

    Identifiers

    Names

    Common name
    Δ4-tetrahydrocannabinol (Δ6a,7-THC)
    IUPAC name
    (9R,10aR)-6,6,9-trimethyl-3-pentyl-8,9,10,10a-tetrahydrobenzo[c]chromen-1-ol
    Other names
    Δ6a,7-THC · delta-6a(7)-THC · delta-4-THC

    Identifiers

    Formula
    C₂₁H₃₀O₂
    CAS
    59042-44-3
    InChIKey
    UQOUHXDCXBITSF-GDBMZVCRSA-N
    SMILES
    CCCCCC1=CC2=C([C@@H]3C[C@@H](CC=C3C(O2)(C)C)C)C(=C1)O

    Machine-readable entry (JSON)

    LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.